7/106 sources · 5 publishersUpdated Oct 22, 11:57 UTC
RELX posts 7% underlying revenue growth for first nine months and reaffirms full‑year outlook
RELX reported underlying revenue growth of 7% for the first nine months of 2026, with the Legal division up 10%, Risk up 8%, Scientific, Technical & Medical up 6% and Exhibitions up 4% year‑to‑date. The company reaffirmed its FY‑2026 revenue, profit and earnings‑per‑share targets and announced a £125 million share‑buyback. The update lifted the ADR 1.2% in pre‑market trading.
Why it matters
The company expects adjusted operating profit to grow faster than revenue across most divisions, which could support earnings momentum (the company says). The £125 million buyback may provide additional support to the share price.
Key facts
- 1Underlying revenue grew 7% year‑to‑date on a constant‑currency basis. finanznachrichten.de
- 2Legal division underlying revenue grew 10% year‑to‑date on a constant‑currency basis. finanznachrichten.de
- 3Risk division underlying revenue grew 8% year‑to‑date on a constant‑currency basis. finanznachrichten.de
- 4Scientific, Technical & Medical division underlying revenue grew 6% year‑to‑date on a constant‑currency basis. finanznachrichten.de
- 5Exhibitions division underlying revenue grew 4% year‑to‑date on a constant‑currency basis. finanznachrichten.de
- 6RELX announced a £125 million share‑buyback. investing.com
Summary written by AlphAI AI Desk from 6 of 6 sources. Not investment advice. Figures are as stated by the linked sources.